Analgesics in Japan

Date: November 9, 2016
Pages: 28
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A8742053AE0EN
Leaflet:

Download PDF Leaflet

Analgesics in Japan recorded healthy current value growth of 3% in 2016 to exceed sales of JPY164 billion. Topical analgesics/anaesthetic commanded a 61% share of overall analgesic value sales, with systemic analgesics accounting for the remaining 39%. In systemic analgesics, adult combination products remained dominant with a 78% share of value sales.

Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
  Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Competitive Positioning
  Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2016
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 4 Taisho Pharmaceutical Co Ltd: Key Facts
  Summary 5 Taisho Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
  Summary 6 Taisho Pharmaceutical Co Ltd: Competitive Position 2016
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
  Summary 7 Takeda Pharmaceutical Co Ltd: Key Facts
  Summary 8 Takeda Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
  Summary 9 Takeda Pharmaceutical Co Ltd: Competitive Position 2016
Executive Summary
Consumer Health Industry Benefits From the Growing Self-medication Trend
Sales Also Boosted by Demand From Inbound Tourists
Competitive Environment Remains Fragmented
Drugstores/parapharmacies Gain Share
Further Positive Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Continues To Increase
Channels
Inbound Tourism Boosts Demand
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 10 OTC: Switches 2014-2016
Sources
  Summary 11 Research Sources
Skip to top


OTC Pharmaceuticals in Japan US$ 350.00 Sep, 2016 · 35 pages
Adult Mouth Care in Japan US$ 990.00 Nov, 2016 · 25 pages
Calming and Sleeping in Japan US$ 990.00 Mar, 2015 · 24 pages

Ask Your Question

Analgesics in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: